Performance Highlights
Consolidated Statements of Income
Net Sales
Operating Profit and Profit (Loss) Attributable to Owners of Parent
※Accounting Standard for Revenue Recognition (ASBJ Statement No.29), etc. has been applied since the beginning of fiscal year ending November 30, 2022.
Consolidated Balance Sheets
Total Assets and Net Assets
Other Indexes
Equity Ratio
ROE
Segment
Fine Chemicals Net Sales
Health & Beauty Care, Food Net Sales
Medical Net Sales
Industrial Chemicals Net Sales
Social Impact Net Sales
※Accounting Standard for Revenue Recognition (ASBJ Statement No.29), etc. has been applied since the beginning of fiscal year ending November 30, 2022.
※The business segment of IWAKI SEIYAKU SAKURA FACTORY CO., LTD. has been changed from the former "Medical Business" to the "Fine Chemicals Business since the beginning of fiscal year ending November 30, 2024.
※For the year ended November 30, 2023, the figures are retroactively presented as new segments. Prior to the fi fiscal year ending November 30, 2022, the former segment is used.
※The Social Impact Business is a new business established in the fiscal year ended November 30, 2022.
Consolidated Performance Highlights
※Accounting Standard for Revenue Recognition (ASBJ Statement No.29), etc. has been applied since the beginning of fiscal year ending November 30, 2022.
※The business segment of IWAKI SEIYAKU SAKURA FACTORY CO., LTD. has been changed from the former "Medical Business" to the "Fine Chemicals Business since the beginning of fiscal year ending November 30, 2024.
※For the year ended November 30, 2023, the figures are retroactively presented as new segments. Prior to the fi fiscal year ending November 30, 2022, the former segment is used.
※The Social Impact Business is a new business established in the fiscal year ended November 30, 2022.